Zoetis | ZTS - Ebitda


Zoetis reported $939M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Align Technology USD 229.14M 31.74M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Dentsply International USD 129M 6M Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Henry Schein USD 288M 1000K Jun/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
J&J USD 8.27B 1.08B Mar/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Neogen USD 45.4M 2.8M Mar/2026
Pacira USD 48.67M 8.43M Jun/2026
Perrigo USD 141.6M 1.34B Mar/2026
Pfizer USD 6.01B 18M Jun/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Quest Diagnostics USD 648M 91M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Sanofi EUR 2.72B 2.94B Mar/2026
Zoetis USD 939M 0 Mar/2026